Improved accuracy of anticoagulant dose prediction using a pharmacogenetic and artificial neural network-based method

Comparison of multiple linear regression, partial least squares and artificial neural networks for prediction of gas chromatographic relative retention times of trimethylsilylated anabolic androgenic steroids

(2012) A.G. Fragkaki et al.   JOURNAL OF CHROMATOGRAPHY A

Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results

(2012) V. PENGO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Management of Venous Thromboembolism

(2012) Bruce Burnett   PRIMARY CARE

Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy

(2011) I. Y. Gong et al.   BLOOD

VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children

(2011) T. T. Biss et al.   BLOOD

The Relative Cost-Effectiveness of Anticoagulants

(2011) Jerry Avorn   CIRCULATION

Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA

(2011) M. Wieloch et al.   EUROPEAN HEART JOURNAL

Bleeding with anticoagulant treatments

(2011) G. Palareti   Hamostaseologie

Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy

(2011) Petra Lenzini et al.   THROMBOSIS AND HAEMOSTASIS

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

(2010) N. A. Limdi et al.   BLOOD

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing

(2010) P Lenzini et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Influence ofCYP2C9andVKORC1Polymorphisms on Warfarin and Acenocoumarol in a Sample of Lebanese People

(2010) Maria O. Esmerian et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Prediction Models for Early Risk Detection of Cardiovascular Event

(2010)   Purwanto et al.   JOURNAL OF MEDICAL SYSTEMS

Warfarin Genotyping Reduces Hospitalization Rates

(2010) Robert S. Epstein et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose

(2009) Fumihiko Takeuchi et al.   PLoS Genetics

The largest prospective warfarin-treated cohort supports genetic forecasting

(2008) M. Wadelius et al.   BLOOD

Pharmacology and Management of the Vitamin K Antagonists

(2008) Jack Ansell et al.   CHEST

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

(2008) BF Gage et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations

(2008) Alan HB Wu et al.   PHARMACOGENOMICS